Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124856912 | 12485691 | 2 | F | 20160605 | 20160913 | 20160621 | 20160919 | EXP | PHHY2016VE085230 | NOVARTIS | 44.62 | YR | F | Y | 0.00000 | 20160919 | CN | COUNTRY NOT SPECIFIED | VE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124856912 | 12485691 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 800 MG, QD | 22068 | 800 | MG | CAPSULE | QD | ||||||
| 124856912 | 12485691 | 2 | I | TASIGNA | NILOTINIB | 1 | Oral | 800 MG, QD | 22068 | 800 | MG | CAPSULE | QD | ||||||
| 124856912 | 12485691 | 3 | I | ATAMEL | ACETAMINOPHEN | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124856912 | 12485691 | 1 | Chronic myeloid leukaemia |
| 124856912 | 12485691 | 3 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124856912 | 12485691 | Drug interaction | |
| 124856912 | 12485691 | Hypersensitivity | |
| 124856912 | 12485691 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124856912 | 12485691 | 1 | 20160523 | 201606 | 0 | |
| 124856912 | 12485691 | 2 | 20160614 | 0 |